Revance Therapeutics shares owned by Nottingham Advisors
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Nottingham Advisors
from 13F filings
Historical chart of Nottingham Advisors investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Nottingham Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Nottingham Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $105k | 12k | 8.79 |
| 2023-09-30 | $137k | 12k | 11.47 |
| 2023-06-30 | $303k | 12k | 25.31 |
| 2023-03-31 | $392k | 12k | 32.21 |
| 2022-12-31 | $246k | 13k | 18.46 |
| 2022-09-30 | $359k | 13k | 26.97 |
| 2022-06-30 | $184k | 13k | 13.82 |
| 2022-03-31 | $260k | 13k | 19.53 |
| 2021-12-31 | $217k | 13k | 16.30 |
| 2021-09-30 | $371k | 13k | 27.87 |
| 2021-06-30 | $395k | 13k | 29.67 |
| 2021-03-31 | $372k | 13k | 27.94 |
| 2020-12-31 | $377k | 13k | 28.32 |
| 2020-09-30 | $335 | 13k | 0.03 |
| 2020-06-30 | $349k | 13k | 26.22 |
| 2020-03-31 | $167k | 11k | 14.76 |
| 2019-12-31 | $162k | 10k | 16.19 |
| 2019-09-30 | $130k | 10k | 12.99 |
| 2019-06-30 | $130k | 10k | 12.99 |
| 2019-03-31 | $158k | 10k | 15.79 |
| 2018-12-31 | $281k | 11k | 24.84 |
| 2018-09-30 | $281k | 11k | 24.84 |
| 2018-06-30 | $348k | 11k | 30.76 |
| 2018-03-31 | $348k | 11k | 30.76 |
| 2017-12-31 | $404k | 11k | 35.71 |
| 2017-09-30 | $312k | 11k | 27.58 |
| 2017-06-30 | $351k | 13k | 26.37 |
| 2017-03-31 | $277k | 13k | 20.81 |
| 2016-12-31 | $276k | 13k | 20.73 |
| 2016-09-30 | $216k | 13k | 16.23 |
| 2016-06-30 | $222k | 16k | 13.61 |
| 2016-03-31 | $626k | 18k | 34.16 |
| 2015-12-31 | $626k | 18k | 34.16 |
| 2015-09-30 | $545k | 18k | 29.74 |
| 2015-06-30 | $586k | 18k | 31.97 |
| 2015-03-31 | $389k | 19k | 20.73 |
| 2014-12-31 | $390k | 23k | 16.94 |